<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac involvement is a not uncommon complication in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Herein, the case is reported of <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> in a female patient with Libman-Sacks <z:hpo ids='HP_0100584'>endocarditis</z:hpo> and with primary APS diagnosed eight years previously </plain></SENT>
<SENT sid="2" pm="."><plain>Aggressive anticoagulation therapy and medical treatment for the <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> over a 12-month period resulted in a partial regression of the severe <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Close clinical and echocardiographic surveillance during the follow up of patients with APS and <z:e sem="disease" ids="C0018824" disease_type="Disease or Syndrome" abbrv="">heart valve disease</z:e> is mandatory </plain></SENT>
<SENT sid="4" pm="."><plain>Optimal treatment, including adequate aggressive anticoagulation therapy and specific treatment for <z:hpo ids='HP_0001635'>heart failure</z:hpo>, may play a pivotal role in reducing the severity of valve dysfunction in these patients </plain></SENT>
</text></document>